LEO 32731 ("Study Drug") is an investigational drug which is being developed by LEO Pharma
A/S ("the Sponsor") for treatment of psoriasis. The aim (s) of this Study are to determine:
- The safety and tolerability of the Study Drug and any side effects that might be
associated with it
- The Study will also measure how much of the Study Drug that gets into the blood and how
long time it takes for the body to remove it.